NCT00137176View on ClinicalTrials.gov

EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2008

Conditions
Multiple Sclerosis
Interventions
DRUG

Rebif

Rebif 44mcg TIW

Trial Locations (1)

27599

University of North Carolina-Chapel Hill MS Clinic Within the Neuroscience Hospital, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT00137176 - EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis | Biotech Hunter | Biotech Hunter